FCGR3B and systemic lupus erythematosus: In addition to the 3.6-fold increase in the susceptibility of developing SLE observed in the single FCGR3B deletion, an additive effect was observed when there was in a deletion of both FCGR3B and ADAM3A genes, leading to a 5.9-fold increase risk for SLE.